` FLUI (Fluicell AB) vs OMX Stockholm 30 Comparison - Alpha Spread

F
FLUI
vs
O
OMX Stockholm 30

Over the past 12 months, FLUI has underperformed OMX Stockholm 30, delivering a return of -23% compared to the OMX Stockholm 30's +11% growth.

Stocks Performance
FLUI vs OMX Stockholm 30

Loading
FLUI
OMX Stockholm 30
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
FLUI vs OMX Stockholm 30

Performance Gap Between FLUI and OMXS30
HIDDEN
Show

Performance By Year
FLUI vs OMX Stockholm 30

Loading
FLUI
OMX Stockholm 30
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Fluicell AB vs Peers

OMX Stockholm 30
FLUI
ABT
ISRG
BSX
SYK
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Fluicell AB
Glance View

Market Cap
15.2m SEK
Industry
Health Care

Fluicell AB engages in the provision of fluid platforms for multi-functional pipettes for cell-based pharmacology research. The company is headquartered in Moelndal, Vastra Gotalands. The company went IPO on 2018-04-18. The company commercializes a product portfolio for processing and studying of individual cells, primarily in the field of drug development. The Company’s products comprise research tools BioPen and Dynaflow Resolve. Tools enable researchers to study, process and measure drug impact on individual cells. Also, the Company develops bioprinting technology Biopixlar Retina in both two-dimensional (2D) and three-dimensional (3D) options. Biopixlar Retina creates complex tissue-like structures with control over positioning of individual cells.

FLUI Intrinsic Value
HIDDEN
Show
Back to Top